← All trials
NCT07239999
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 12, 2026
- Primary completion
- Dec 4, 2026
- Completion date
- Jan 15, 2027
- First posted
- Nov 20, 2025
- Last posted
- Nov 20, 2025
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of CanadaLead sponsor
- Government of CanadaSponsor investigator
- Dalhousie UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.